Daiichi Sankyo (PK) Stock Quote DSKYF - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

31.12

Bid

30.96

Ask

34.40

Volume

856

30.96 Day's Range 34.24

23.45 52 Week Range 44.64

Market Cap

59.65B

Previous Close

32.58

Open

30.96

Last Trade

30.96

Last Trade Time

12:55:32

Financial Volume

$ 27,272

VWAP

31.86

Average Volume (3m)

2,511

Shares Outstanding

1,916,787,029

Dividend Yield

16,252.96%

PE Ratio

0.30

Earnings Per Share (EPS)

104.72

Revenue

1.63T

Net Profit

200.73B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Biolog/vaccines

Website

www.daiichisankyo.co.jp

Headquarters

Chuo, Tokyo, Jpn

Founded

2005

Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was $32.58. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of $ 23.45 to $ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares outstanding. The market capitalization of Daiichi Sankyo (PK) is $62.45 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.30.

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

Venue Change

Tue, Oct 08, 2013 12:00 - Daiichi Sankyo Co., Ltd. (DSKYF: OTC Link) - Venue Change - The symbol, DSKYF, no longer trades on Grey Market. As of Tue, Oct 08, 2013, DSKYF trades on OTC Link. You...

Glaxo Files for Two Flu Vaccines - Analyst Blog

Recently, GlaxoSmithKline (GSK) announced that it has filed marketing applications for two influenza vaccines. The vaccines, up for approval, include a quadrivalent influenza vaccine for the...

Glaxo and Daiichi to Set Up JV - Analyst Blog

British drugmaker GlaxoSmithKline (GSK) recently announced that it has signed an agreement with Daiichi Sankyo (DSKYF) to form a joint venture (JV). The JV will be called Japan Vaccine Co., Ltd...

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.69	-5.15086863761	32.81	37.1	30.96	1740	34.51649155	CS
4	-8.02	-20.4905467552	39.14	44.64	30.96	3066	37.70555574	CS
12	-4.78	-13.3147632312	35.9	44.64	30.96	2511	38.10321261	CS
26	-1.3	-4.00987045034	32.42	44.64	28.22	15679	32.13492156	CS
52	3.12	11.1428571429	28	44.64	23.45	10294	31.30439781	CS
156	3.8	13.9092240117	27.32	44.64	19.45	7928	30.05804616	CS
260	-33.23	-51.6394716395	64.35	95.96	17.61	6377	30.89006241	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TMPOQTempo Automation Holdings Inc (CE)	$ 0.0068 (679,900.00%)	607
JUVAFJuva Life Inc (CE)	$ 0.003 (299,900.00%)	78.81k
SPRNSupernova Energy Inc (CE)	$ 0.0002 (19,900.00%)	100
SIRCSolar Integrated Roofing Corporation (PK)	$ 0.0001 (9,900.00%)	17.89M
JRJCYChina Finance Online Company Ltd (CE)	$ 0.0001 (9,900.00%)	598
ROYERoyal Energy Resources Inc (CE)	$ 0.000001 (-100.00%)	2.8k
ZHCLFZenith Capital Corporation (CE)	$ 0.000001 (-100.00%)	12.18k
AHELFAuscan Resources Inc (CE)	$ 0.000001 (-100.00%)	100
RQHTFReliq Health Technologies Inc (CE)	$ 0.0001 (-99.75%)	2.5k
AGCZAndes Gold Corp (CE)	$ 0.0002 (-99.50%)	3.11k
RDARRaadr Inc (PK)	$ 0.0004 (14.29%)	190.38M
ICNMIcon Media Holdings Inc (PK)	$ 0.0004 (0.00%)	106.84M
GRLFGreen Leaf Innovations Inc (PK)	$ 0.0001 (0.00%)	72.91M
HMBLHUMBL Inc (PK)	$ 0.00015 (0.00%)	67.58M
HCMCHealthier Choices Management Corporation (PK)	$ 0.0001 (9,900.00%)	63.18M